For the chronic toxicity studies, PAS-004 was administered in crystalline form and demonstrated a similar adverse event profile and equivalent NOAEL in dogs as compared to the original amorphous ...

Hammering across the rippled, hard-packed off-road trails of Johnson Valley California, northeast of Big Bear Lake, the 2024 ...

The FDA has lifted a clinical hold on a Peninsula company's hyperinsulinism trial, allowing study to start early next year.

Rezolute Inc said on Monday the U.S. Food and Drug Administration had lifted its partial clinical hold on a late-stage study ...

Rising Pharmaceuticals, Inc. announces commercial availability of Edetate calcium disodium injection in the United States ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

According to the Ozempic prescribing information, you should stop taking Ozempic at least two months before a planned ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and ...

Ractigen's therapy candidate RAG-17 was safe across all tested doses and showed early signs of effectiveness in SOD1-ALS ...

African giant pouched rats proved adept at detecting four commonly trafficked products derived from endangered species ...

Researchers from Japan Tobacco Inc. presented the discovery and preclinical characterization of novel highly potent Keap1-Nrf2 protein-protein interaction (PPI) inhibitors.

Esketamine (Spravato) was the first new depression treatment in decades. It brought depressed people hope. It also brought ...